Overview

A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.

Status:
RECRUITING

Trial end date:
2026-02-28

Target enrollment:

Participant gender:

Summary

THN391-OPT-101 is a study assessing safety and preliminary efficacy of THN391 in patients with diabetic macular edema (DME) given as monotherapy.

Phase:

PHASE1

Details

Lead Sponsor:

Therini Bio Pty Ltd